<p>The present invention discloses compounds of Formula I wherein the variables in Formula I are defined as described herein. Also disclosed are pharmaceutical compositions containing such compounds and methods for using the compounds of Formula I in the prevention or treatment of HCV infection.</p>
申请公布号
CA2900321(A1)
申请公布日期
2014.09.12
申请号
CA20142900321
申请日期
2014.03.03
申请人
F. HOFFMANN-LA ROCHE AG
发明人
CHEN, ZHI;CHIN, ELBERT;ERICKSON, SHAWN DAVID;GABRIEL, STEPHEN DEEMS;MERTZ, ERIC;WEIKERT, ROBERT JAMES
